Evidence on the cost of breast cancer drugs is required for rational decision making

BACKGROUND: For rational decision making, assessing the cost-effectiveness and budget impact of new drugs and comparing the costs of drugs already on the market is required. In addition to value frameworks, such as the American Society of Clinical Oncology Value Framework and the European Society of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ecancermedicalscience
Autores principales: Berghuis, Anne Margreet Sofie, Koffijberg, Hendrik, Terstappen, Leonardus Wendelinus Mathias Marie, Sleijfer, Stefan, IJzerman, Maarten Joost
Formato: Artigo
Lenguaje:Inglês
Publicado: Cancer Intelligence 2018
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931813/
https://ncbi.nlm.nih.gov/pubmed/29743945
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2018.825
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares